HSP90AA1 and metabolic disease: These findings highlight Hsp90 as a central regulator of cardiac fibrosis, hypertrophy, inflammation, and metabolic dysfunction, suggesting that targeted modulation of Hsp90 could be a promising therapeutic strategy for cardiovascular and metabolic diseases.